SALT LAKE CITY, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will hold a conference call on Wednesday, Feb 9, 2011 at 4:30 p.m. ET (1:30 p.m. PT) to discuss financial results for its fiscal second quarter 2011 ended December 31, 2010.
